Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial.
<h4>Background</h4>Clinical trials in the research setting have demonstrated that primary human papillomavirus (HPV)-based screening results in greater protection against cervical cancer compared with cytology, but evidence from real-life implementation was missing. To evaluate the effec...
Guardado en:
Autores principales: | K Miriam Elfström, Carina Eklund, Helena Lamin, Daniel Öhman, Maria Hortlund, Kristina Elfgren, Karin Sundström, Joakim Dillner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84318018bd084149bed7e65d93180117 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Type-specific human papillomavirus biological features: validated model-based estimates.
por: Iacopo Baussano, et al.
Publicado: (2013) -
Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.
por: Matejka Rebolj, et al.
Publicado: (2014) -
Risk for SARS-CoV-2 infection in healthcare workers outside hospitals: A real-life immuno-virological study during the first wave of the COVID-19 epidemic.
por: Maria Fröberg, et al.
Publicado: (2021) -
Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women.
por: Ruth Tachezy, et al.
Publicado: (2013) -
Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines
por: Lina Mouna, et al.
Publicado: (2021)